Sonim Technologies forms special committee to evaluate strategic alternatives after AJP Holding 13D/A

DNA X, Inc.

Special Committee comprised of Mike Mulica (chair) and James Cassano, both independent directors.
Roth Capital Partners engaged as financial advisor to evaluate options including sale or merger.
Orbic North America LLC identified as one of multiple parties expressing strategic interest.
Press release confirms inbound interest following January 17, 2025 Schedule 13D/A filing by AJP Holding Company.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.